Oxford BioDynamics (LON:OBD) Shares Break Below 50 Day Moving Average – Time to Sell?

Oxford BioDynamics Plc (LON:OBD – Get Free Report) crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of GBX 0.11 and traded as low as GBX 0.10. Oxford BioDynamics shares last traded at GBX 0.10, with a volume of 78,381,070 shares traded.

Oxford BioDynamics Stock Performance

The company has a quick ratio of 2.80, a current ratio of 2.01 and a debt-to-equity ratio of 131.61. The company’s 50-day moving average is GBX 0.11 and its two-hundred day moving average is GBX 0.16. The company has a market capitalization of £13.44 million, a P/E ratio of -0.50 and a beta of 0.42.

About Oxford BioDynamics

(Get Free Report)

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases. Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022. In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.

Recommended Stories

Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.